Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: A double-blind, randomized, placebo-controlled trial

International Journal of Food Sciences and Nutrition

Volumn 64, Issue 1, 2013, Pages 7-15

  Rondanelli, Mariangela ^a   Giacosa, Attilio ^b   Opizzi, Annalisa ^a   Faliva, Milena Anna ^a   Sala, Patrizio ^a   Perna, Simone ^a   Riva, Antonella ^c   Morazzoni, Paolo ^c   Bombardelli, Ezio ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b Policlinico di Monza   (Italy)

^c INDENA S P A   (Italy)

Author keywords

Artichoke leaf extract; Chlorogenic acid; Cholesterol; Dietary supplement; HDL cholesterol; Luteolin

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT;

ADULT; ARTICHOKE; ARTICLE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; OBESITY; PHYTOTHERAPY; PLANT LEAF; RANDOMIZED CONTROLLED TRIAL;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYNARA SCOLYMUS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; OVERWEIGHT; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES;

CYNARA SCOLYMUS;

EID: 84872027505     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2012.700920     Document Type: Article

References (36)

1. American Heart Association 1988. Dietary guidelines for healthy American adults. A statement for physicians and health professional by the Nutrition Committee. Circulation 77: 721A-724A.
2. Andersson LO. 1997. Pharmacology of apolipoprotein A-I. Curr Opin Lipidol 8:225-228.
3. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al. 1995. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation 91: 2488-2496.
4. Boden WE. 2000. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86:19L-22L.
5. Brown JE, Rice-Evans CA. 1998. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro. Free Radic Res 29:247-255.
6. Bundy R, Walker AF, Middleton RW, Wallis C, Simpson HC. 2008. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthyhypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomedi-cine 15:668-675.
7. Englisch W, Beckers C, Unkauf M, Ruepp M, Zinserling V. 2000. Efficacy of Artichoke dry extract in patients with hyperlipopro-teinemia. Arzneimittelforschung 50:260-265.
8. Eriksson M, Carlson LA, Miettinen TA, Angelin B. 1999. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I: potential reverse cholesterol transport in humans. Circulation 100:594-598.
9. Forster-Coull L, Barr SI, Levy-Milne R. 2004. British Columbia nutrition survey: report on food group use. Victoria: British Columbia Ministry of Health Services.
10. Frisancho AR. 1984. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr 40: 808-819.
11. Gebhardt R. 2002. Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreat-ment. Phytother Res 16:368-372.
12. Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S. 2009. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Am J Cardiol 130:41-45.
13. Gordon T, Castelli WP, Hjotland MC, Kannel WB, Dawber TR. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 62: 707-714.
14. Gouédard C, Barouki R, Morel Y. 2004. Dietary poly-phenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 24: 5209-5222.
15. Gould AL, Davies GM, Alemao E, Yin DD, Cook Jr. 2007. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther 29:778-794.
16. Gugliucci A, Bastos DH. 2009. Chlorogenic acid protects paraoxonase 1 activity in high density lipoprotein from inactivation caused by physiological concentrations of hypo-chlorite. Fitoterapia 80:138-142.
17. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. 1998. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234.
18. Kawahiri M, Maugeais C, Rader D. 2000. High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis. Curr Atheroscler Rep 2:363-372.
19. Keys A. 1997. Coronary heart disease in seven countries. Nutrition 13:250-252.
20. Kostapanos MS, Milionis HJ, Elisaf MS. 2010. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Am J Cardiovasc Drugs 10: 11-28.
21. Küskü-Kiraz Z, Mehmetçik G, Dogru-Abbasoglu S, Uysal M. 2010. Artichoke leaf extract reduces oxidative stress and lipoprotein dyshomeostasis in rats fed on high cholesterol diet. Phytother Res 24:565-570.
22. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, American Heart Association Statistics Committee and Stroke Statistics Subcommittee et al. 2010. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: 948-954
23. Erratum in: Circulation (2010) 121:e259.
24. Lupattelli G, Marchesi S, Lombardini R, Roscini AR, Trinca F, Gemelli F, et al. 2004. Artichoke juice improves endothelial function in hyperlipemia. Life Sci 76:775-782.
25. Mensink RP, Zock PL, Kester AD, Katan MB. 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77: 1146-1155.
26. Mooradian AD. 2003. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med 163: 33-40.
27. Pandino G, Courts FL, Lombardo S, Mauromicale G, Williamson G. 2010. Caffeoylquinic acids and flavonoids in the immature inflorescence of globe artichoke, wild cardoon, and cultivated cardoon. J Agric Food Chem 58:1026-1031.
28. Qiang Z, Lee SO, Ye Z, Wu X, Hendrich S. 2011. Artichoke extract lowered plasma cholesterol and increased fecal bile acids in golden Syrian hamsters. Phytother Res [Epub ahead of print]. doi:10.1002/ptr.3698.
29. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FS, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. 1999. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipo-protein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341: 410-418.
30. Sierksma A, van der Gaag MS, van Tol A, James RW, Hendriks HF. 2002. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers. Alcohol Clin Exp Res 26: 1430-1435.
31. Sirtori CR, Galli C, Anderson JW, Arnoldi A. 2009. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: focus on dietary proteins. Atherosclerosis 203:8-17.
32. Thompson Coon JS, Ernst E. 2003. Herbs for serum cholesterol reduction: a systematic view. J Fam Pract 52: 468-478.
33. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR. 1998. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23). Br Med J 316: 823-828.
34. van der Gaag MS, van Tol A, Scheek LM, James RW, Urgert R, Schaafsma G, Hendriks HFJ. 1999. Daily moderate alcohol consumption increases serum paraoxonase activity: a diet-controlled, randomized intervention study in middle-aged men. Atherosclerosis 147:405-410.
35. Wegener T, Fintelmann V. 1999. Pharmacological properties and therapeutic profile of artichoke (Cynara scolymus L.). Wien Med Wochenschr 149:241-247.
36. Wider B, Pitter MH, Thompson-Coon J, Ernst E. 2009. Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst Rev, CD003335.